Servier Russia Deploys IMS Health’s Nexxus Mobile Intelligence CRM Solution To Drive Commercial Effectiveness

Scalable Cloud-Based Platform Seamlessly Supports More Productive Customer Engagement

IMS Health (NYSE:IMS) today announced that Servier Russia, a Groupe Servier subsidiary, is deploying the Nexxus™ Mobile Intelligence CRM solution to drive the efficiency and performance of its sales force. Drawing from uniquely broad and diverse data sources that include IMS Health, client and third-party information, Nexxus MI curates insights that will enable Servier Russia’s commercial team to create precision conversations with customers across multiple channels for more productive engagement.

Nexxus MI helps life sciences companies implement their national brand strategies at local levels by connecting continuously updated industry and company intelligence with strategic decision-support tools. Field teams can interact with their customers using preferred communications channels on any digital device, anytime and anywhere. In addition, offline access to most Nexxus MI functions benefits customer-facing teams that spend significant time working in locations where connectivity may not be available. Servier Russia will leverage the IMS Health scalable cloud-based solution to execute effective commercial strategies for reaching the right customers across the right channels with the right messages.

“With a strong presence in Russia’s pharmaceutical market, our goal is to continue advancing the use of innovative treatment options throughout the country, with high efficiency,” said Yana Rostovtseva, operational manager, Servier Russia. “IMS Health’s Mobile Intelligence solution brings together the information and analytics to accelerate performance at every level of our commercial operations. It puts powerful mobile flexibility and functionality directly into the hands of our field sales force for maximum impact.”

Nexxus MI is part of the Nexxus Commercial Application Suite, which brings together the most complete and fully connected set of applications across the commercial continuum—from marketing campaign management and social media monitoring to customer engagement, sales operations and performance management. The ability to easily integrate Nexxus MI with Servier Russia’s existing systems was a key factor in the company’s decision to select the IMS Health solution.

“We are excited to expand our partnership with Servier Russia and support its continued success in this dynamic market,” said Robert Chu, IMS Health senior vice president, Technology Solutions. “Today, multinational companies increasingly are looking to make every customer interaction an intelligent one through the best information and technologies. IMS Health is able to help its clients achieve that goal.”

For more information about Nexxus MI and the Nexxus Commercial Application Suite, visit www.imshealth.com.

About IMS Health

IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. Our 7,500 services experts connect configurable SaaS applications to 10+ petabytes of complex healthcare data in the IMS One™ cloud platform, delivering unique insights into diseases, treatments, costs and outcomes. The company’s 15,000 employees blend global consistency and local market knowledge across 100 countries to help clients run their operations more efficiently. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes. Additional information is available at www.imshealth.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160314006456/en/

IMS HealthTor Constantino, [e-mail]